340bemployed.org

Your Free Source for 340B News and Commentary

  • Home
  • About Us
  • Employers
  • Job Seekers
  • Advertise
  • 340B Health

HRSA Readies New 340B Patient Definition for Publication

Guidance will have a major effect on how drug discounts can be used.
 

Print Article

January 26, 2011—The Health Resources and Services Administration (HRSA) has sent the White House a new definition of “patient” for purposes of 340B drug discounts for review prior to its publication in the Federal Register.

According to an agency spokesperson, HRSA also intends to formally withdraw its controversial January 2007 proposed patient definition, which provider groups strongly opposed and kept bottled up for four years with help from 340B backers in Congress.

The Office of Management and Budget (OMB), which reviews all drafts of proposed and final federal agency regulations, disclosed the HRSA submissions on its Web site on Jan. 21. Although such reviews are technically required to last no more than 90 days, the head of an agency making the submission can extend the review indefinitely, as was the case with the 2007 proposal.

Contents Are Unknown

The contents of HRSA’s new proposed definition are unknown. It is also unclear whether the notice under review is “proposed,” “final” or “interim.” A HRSA spokesperson said it was submitted in the form of a “notice with comment,” but added that this designation could change during the review process. Comparable notices recently promulgated by different agencies took effect either immediately or in a matter of weeks or months.

How the agency chooses to define “patient” has a cascading effect throughout the entire 340B program, directly affecting the kinds and quantities of drugs that enrolled providers can buy at deeply discounted prices.

Proposed Restrictions Decried

Safety Net Hospitals for Pharmaceutical Access (SNHPA), which represents more than 600 hospitals enrolled in 340B, argued that the 2007 proposed definition was far too restrictive and would have imposed an enormous burden on pharmacists and other providers to verify patient eligibility. Together with other 340B provider groups, it said that if the proposed guidelines were published, they would have undermined providers to such a degree that many would have been unable to continue to serve their indigent and uninsured patients.

The drug industry, meanwhile, has long contended that 340B providers have stretched the current guidelines, which were issued in 1996, much too broadly, leading to impermissible drug diversion. The National Community Pharmacists Association (NCPA), which represents independent pharmacies, has taken a similar position, arguing that the definition should be strictly limited to indigent and uninsured patients. Not all independent pharmacies share this view, however, as many serve as 340B contract pharmacies.

SNHPA officials say they hope the final guidelines will reflect the changes that they and other 340B provider groups recommended. They say they are concerned, however, that common uses of the program, such as for employees and other populations receiving covered entity services outside covered entity facilities, may be in jeopardy.

Follow us on X

340B Health Follow

340B Health is the leading advocate & resource for hospitals that serve their communities by participating in the 340B drug pricing program. #Protect340B

340BHealth
340bhealth 340B Health @340bhealth ·
16 Feb

There’s a reason why you may have been hearing some controversial things about #340B lately. These misinformation campaigns go way back and have trails leading to Big Pharma. Learn why pharma-funded groups are invested in derailing a federal program that doesn’t cost the…

Reply on Twitter 1890990490486726953 Retweet on Twitter 1890990490486726953 1 Like on Twitter 1890990490486726953 3 Twitter 1890990490486726953
340bhealth 340B Health @340bhealth ·
15 Feb

It would cost just one safety-net hospital $24 million more each year to pay full price for two @JNJNews drugs upfront and wait for drugmaker rebates that might never come.

Then consider the crippling financial harm that would occur if you were to expand those costs to purchase…

Reply on Twitter 1890756196560482421 Retweet on Twitter 1890756196560482421 1 Like on Twitter 1890756196560482421 1 Twitter 1890756196560482421
340bhealth 340B Health @340bhealth ·
14 Feb

Show the team of experts here at #340B Health some love this Valentine’s Day by streaming our “listener mailbag” episode of #340BInsight: http://bit.ly/3YWHlJ4. Then learn more in just over a week at the @340BCoalition Winter Conference in San Diego!

Reply on Twitter 1890392047640527294 Retweet on Twitter 1890392047640527294 Like on Twitter 1890392047640527294 Twitter 1890392047640527294
Load More

RSS 340B Informed

  • An In-Depth Look at Total 340B Purchases
  • Ideas for 340B Changes Could Lead to Legislation
  • Help From 340B After a Rare Diagnosis and an Unaffordable Bill

Copyright © 2025 · 340B Health